Anti-MDA5 Antibody Dermatomyositis Overlap with Systemic Lupus Erythematosus: A Case Report and Review of the Literature



Emily C. Milam1, Jacobo Futran3, Andrew G. Franks Jr.1, 2, *
1 Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, USA
2 Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, USA
3 Hospital for Special Surgery, Rheumatology Division, New York, USA


Article Metrics

CrossRef Citations:
0
Total Statistics:

Full-Text HTML Views: 849
Abstract HTML Views: 364
PDF Downloads: 101
ePub Downloads: 67
Total Views/Downloads: 1381
Unique Statistics:

Full-Text HTML Views: 354
Abstract HTML Views: 194
PDF Downloads: 83
ePub Downloads: 58
Total Views/Downloads: 689



© Milam et al.; Licensee Bentham Open

open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/legalcode), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

* Address correspondence to this author at the Department of Medicine, Division of Rheumatology, New York University School of Medicine, 240 East 38th Street, 11th Floor, New York, N.Y. 10016, USA; Tel: +917-5964685; E-mail: Andrew.Franks@nyumc.org


Abstract

Background:

Dermatomyositis (DM) is an autoimmune connective tissue disease that primarily targets the muscle, skin, and lungs. Many patients have autoantibodies that correspond to distinct clinical phenotypes. Melanoma differentiation-associated gene 5 (anti-MDA5) antibody, a specific antibody that targets the melanoma differentiation-associated gene 5 (MDA5), has been reported in DM cases and is significant for a distinct cutaneous presentation and rapidly progressive interstitial lung disease.

Objective:

Herein, we describe a patient with DM with a positive anti-MDA5 antibody and characteristic clinical phenotype, who subsequently developed coexisting systemic lupus erythematosus (SLE). A diagnosis of SLE was supported by his clinical phenotype, positive serologies, hypocomplementemia, and progression to glomerulonephritis and lupus cerebritis, features of which fulfilled the American College of Rheumatology criteria for SLE.

Conclusion:

DM is known to overlap with other autoimmune diseases, including SLE, and coexistence can lead to a wide variety of clinical presentations. SLE overlapping with anti-MDA5 positive DM may present with distinct clinical features.

Keywords: Connective tissue disease, Dermatomyositis, Melanoma differentiation-associated gene 5 (anti-MDA5), Systemic lupus erythematosus.